New study aims to unravel fatigue in common nerve disease
NCT ID NCT07066683
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study looks at fatigue in people with Charcot-Marie-Tooth type 1A (CMT1A), a nerve disorder affecting arms and legs. Researchers will compare 22 patients with 22 healthy volunteers to measure how fatigue affects walking and balance. They use tests like muscle strength measurements and questionnaires to understand both perceived tiredness and physical fatigability.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better understanding of fatigue in CMT1A, helping design future treatments or therapies to improve mobility and quality of life.
- What could go wrong
- This is a small pilot study (44 participants) that only observes and measures, not testing a treatment. Results may not apply to all CMT1A patients or lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHARCOT-MARIE-TOOTH TYPE 1A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pôle de médecine physique et de réadaptation, Hôpital de Hautepierre, Strasbourg Centre de référence des maladies neuromusculaires, Institut Universitaire de Réadaptation Clémenceau, Strasbourg
Strasbourg, 67000, France